Universal Health International Group Holding Limited (2211.HK)
2211.HK Stock Price Chart
Explore Universal Health International Group Holding Limited interactive price chart. Choose custom timeframes to analyze 2211.HK price movements and trends.
2211.HK Company Profile
Discover essential business fundamentals and corporate details for Universal Health International Group Holding Limited (2211.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
IPO Date
12 Dec 2013
Employees
1.20K
Website
https://www.uhighl.comCEO
Chuanfu Chu
Description
Universal Health International Group Holding Limited, an investment holding company, engages in the distribution, wholesale, and retail of drugs, healthcare products, and other pharmaceutical products in the northeastern region of the People's Republic of China. Its product categories include Chinese patent medicines, chemical preparations, antibiotics and biochemical drugs, traditional Chinese medicine decoction pieces, biological products, protein assimilation preparations, peptide hormones, blood products, disinfection products, medical equipment, prepackaged foods, nutritional foods, health care products, stereotyped packaging cosmetics, and daily necessities, as well as family planning supplies, such as contraceptives and utensils; dairy products comprise infant formula milk powder; etc. The company also provides storage services. It serves pharmaceutical retailers, hospitals, clinics, and distributors. The company was formerly known as Jintian Pharmaceutical Group Limited and changed its name to Universal Health International Group Holding Limited in July 2015. Universal Health International Group Holding Limited was founded in 1998 and is headquartered in Shenyang, the People's Republic of China.
2211.HK Financial Timeline
Browse a chronological timeline of Universal Health International Group Holding Limited corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 25 Feb 2025
EPS came in at -$0.01 , while revenue for the quarter reached $469.30M .
Earnings released on 26 Sept 2024
EPS came in at $0.03 , while revenue for the quarter reached $534.48M .
Earnings released on 28 Feb 2024
EPS came in at -$0.03 , while revenue for the quarter reached $654.50M , missing expectations by -87.67%.
Earnings released on 28 Sept 2023
EPS came in at -$0.11 , while revenue for the quarter reached $540.78M , missing expectations by -89.81%.
Earnings released on 24 Feb 2023
EPS came in at -$0.09 , while revenue for the quarter reached $907.69M , missing expectations by -82.90%.
Earnings released on 30 Jun 2022
EPS came in at -$0.15 , while revenue for the quarter reached $768.98M .
Earnings released on 31 Dec 2021
EPS came in at -$0.38 , while revenue for the quarter reached $755.05M .
Earnings released on 30 Jun 2021
EPS came in at -$1.30 , while revenue for the quarter reached $717.67M .
Earnings released on 31 Dec 2020
EPS came in at -$0.79 , while revenue for the quarter reached $697.64M .
Stock split effective on 29 Dec 2020
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Stock split effective on 14 Dec 2020
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
2211.HK Stock Performance
Access detailed 2211.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.